The POTCAST randomized trial showed that elevating potassium levels to a “high-normal” range (4.5–5.0 mmol/L) reduced the risk of serious heart rhythm events in ICD patients by 24 percent (hazard ratio 0.76) over ~39.6 months. In the study of 1,200 participants (baseline potassium less than or equa…